These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22995479)

  • 1. Pitfalls in the genetic diagnosis of Hb S.
    Moradkhani K; Riou J; Wajcman H
    Clin Biochem; 2013 Mar; 46(4-5):291-9. PubMed ID: 22995479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
    Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
    J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
    J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening shows a high incidence of sickle cell anemia in Central India.
    Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
    Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy for identification by mass spectrometry of a new human hemoglobin variant with two mutations in Cis in the beta-globin chain: Hb S-Clichy [beta6(A3)Glu-->Val; beta8(A5)Lys-->Thr].
    Zanella-Cleon I; Préhu C; Joly P; Riou J; Becchi M; Wajcman H; Francina A
    Hemoglobin; 2009; 33(3):177-87. PubMed ID: 19657831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.
    Kutlar F; Redding-Lallinger R; Meiler SE; Bakanay SM; Borders L; Kutlar A
    Acta Haematol; 2010; 124(2):120-4. PubMed ID: 20861612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity Hb S/Hb Hope (beta 136 Gly-->Asp): a pitfall in the newborn screening for sickle cell disease.
    Ducrocq R; Bévier A; Leneveu A; Maier-Redelsperger M; Bardakdjian-Michau J; Badens C; Elion J
    J Med Screen; 1998; 5(1):27-30. PubMed ID: 9575456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular exclusion of haemoglobin SD disease by prenatal diagnosis.
    Fodor FH; Eng CM
    Prenat Diagn; 1999 Jan; 19(1):58-60. PubMed ID: 10073909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid molecular characterization of Hb Queens and Hb Siam: two variants easily misidentified as sickle Hb.
    Fucharoen S; Singsanan S; Hama A; Fucharoen G; Sanchaisuriya K
    Clin Biochem; 2007 Jan; 40(1-2):137-40. PubMed ID: 17014836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
    Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
    J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of hemoglobin H disease by sickle trait.
    Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
    J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.
    Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH
    Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of Iranian families with sickle cell disease.
    Ayatollahi M; Zakerinia M; Haghshenas M
    J Trop Pediatr; 2005 Jun; 51(3):136-40. PubMed ID: 15831669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of beta-thalassemia mutations in Guadeloupe.
    Romana M; Keclard L; Guillemin G; Lavocat E; Saint-Martin C; Berchel C; Mérault G
    Am J Hematol; 1996 Dec; 53(4):228-33. PubMed ID: 8948659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
    Tubman VN; Bennett CM; Luo HY; Chui DH; Heeney MM
    Pediatr Blood Cancer; 2007 Aug; 49(2):207-10. PubMed ID: 17551985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review.
    Ashley-Koch A; Yang Q; Olney RS
    Am J Epidemiol; 2000 May; 151(9):839-45. PubMed ID: 10791557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel sickle hemoglobin: hemoglobin S-south end.
    Luo HY; Adewoye AH; Eung SH; Skelton TP; Quillen K; McMahon L; Steinberg MH; Chui DH
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):773-6. PubMed ID: 15543018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hb Haaglanden: a new nonsickling β7Glu>Val variant. Consequences for basic diagnostics, screening, and risk assessment when dealing with HbS-like variants.
    Harteveld CL; Ponjee G; Bakker-Verweij M; Arkesteijn SG; Phylipsen M; Giordano PC
    Int J Lab Hematol; 2012 Oct; 34(5):551-5. PubMed ID: 22494447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.